Breakfast and Industry Symposium presented by Histosonics

Intermediate Stage HCC Debate (200)

Moderators: Robert Lewandowski, MD, FSIR; Northwestern Medicine; Nishita Kothary, MD, Stanford School of Medicine; Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

• HCC within UCSF Criteria: TACE Remains the Optimal Strategy for Downstaging, Christos Georgiades, MD, PhD, Johns Hopkins University
• HCC within UCSF Criteria: Y90 has Replaced TACE as Optimal Downstaging Strategy, Irene Bargellini, MD, Candiolo Cancer Institute and University of Turin
• HCC within UCSF Criteria: TACE vs Y90 Discussion, All listed faculty
• Advanced Multifocal HCC: Combination of TACE and Systemic Therapy is Superior to Y90 Combined with Systemic Therapy, Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
• Advanced Multifocal HCC: Combination of Y90 and Systemic Therapy is Superior to TACE Combined with Systemic Therapy, Evan Lehrman, MD, FSIR, California Pacific Medical Center
• Advanced Multifocal HCC: TACE or Y90 with Systemic Therapy Discussion, All listed faculty

Lymphatics (200)

Moderators: Max Itkin, MD, University of Pennsylvania; Robert Liddell, MD, Johns Hopkins School of Medicine

• Thoracic Duct Interventions, Max Itkin, MD, University of Pennsylvania
• Pelvic Lymph Leak, Robert Liddell, MD, Johns Hopkins School of Medicine
• Liver Lymphangiography, Protien-losing Enteropathy, and Chylous Ascites, Gregory Nadolski, MD, University of Pennsylvania
• Malignancy and Lower Extremity Swelling, Pallav Kolli, MD, University of California San Francisco

Biomarkers for Treatment Response (300)

Moderators: Terence P. Gade, MD, PhD, University of Pennsylvania; Mishal Mendiratta-Lala, MD, University of Michigan

• Imaging Biomarkers of Treatment Response in HCC, Mishal Mendiratta-Lala, MD, University of Michigan
• Neuroendocrine Tumors, Etay Ziv, MD, PhD, Memorial Sloan Kettering Cancer Center
• HCC, Terence P. Gade, MD, PhD, University of Pennsylvania
• Cholangiocarcinoma, Christina Mosconi, MD, IRCCS, Policlinico di Sant'orsola Bologna
• ctDNA for GI Malignancies, Adam Burgoyne, MD, PhD, University of California San Diego

Discovery Theatre Programming

• Building IO in Private Practice (All levels)
  • Moderators: Jonathan Steinberger, MD, Cedars Sinai Medical Center ; Charles Nutting, DO, FSIR, Image Guided Therapy

Scientific Oral Abstracts (200)

Moderators: Isabel Gala Newton, MD, PhD, VASDMC and UCSD; Nadine Abi-Jaoudeh, MD, University of California Irvine

Y90 Dosimetry (200)

Moderators: John D. Louie, MD, Stanford University; Beau Toskich, MD, Mayo Clinic

• Dosimetry Updates: HCC and Cholangiocarcinoma, Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
• Dosimetry Updates for Metastatic Disease, Nima Kokabi, MD, University of North Carolina Chapel Hill
• Single Session Mapping and Treatment, Edward Kim, MD, Mount Sinai Health Systems
• Navigating Complex Anatomy, John D. Louie, MD, Stanford University

Lunch and Industry Symposium presented by Boston Scientific

Discovery Theatre Programming

• 12:15 - 12:45 p.m. - Young IO Research Fellowship Presentations (All levels)
  • Moderator: Lynn Savic, MD, Universitätsmedizin Charité Berlin
• 12:45 - 1:00 p.m. - Product Theatre presented by Siemens/Varian

Lung Tumor Board (200)

Moderators: Alda Tam, MD, MD Anderson Cancer Center; Florian J. Fintelmann, MD, Massachusetts General Hospital

• Treatment Modality Selection for Ablation of Lung Nodules, Damian E. Dupuy, MD, FACR, Cape Cod Hopsital and Brown University
• Advanced Techniques in Lung Ablation, Robert Suh, MD, David Geffen School of Medicine at UCLA
• Combination of Local and Systemic Therapies, Claire Mulvey, MD, University of California San Francisco
• Treatment of Oligometastatic Disease in Lung Cancer, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center
• Tumor Board, All session faculty listed above; Michael Pritchett, DO, MPH, FirstHealth of the Carolinas and Pinehurst Medical Center

mCRC Tumor Board (200)

Moderator: Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE, Memorial Sloan Kettering Cancer Center; Bela Kis, MD, PhD, FSIR, Moffitt Cancer Center

• Current Concepts in Ablation for Colorectal Liver Metastases: Lessons Learned from Recent Trials, Grant Schmidt, MD, Mayo Clinic
• Combination Therapy: Y90 with Chemotherapy, Suvranu Ganguli, MD, Boston Medical Center/Boston University School of Medicine
• Oligomets in Colon Cancer, Stephen J. Hunt, MD, PhD, FSIR, University of Pennsylvania
• Role of Chemoembolization for mCRC, Thomas Vogl, MD, Clinic for Radiology and Nuclear Medicine
• Tumor Board, All session faculty listed above, Brendan C. Visser, MD, Stanford University; Sidharth Anand, MD, MBA, UCLA

Discovery Theatre Programming

• 2:45 - 3:15 p.m. - Trials and Tribulations: Getting Started in Clincal Research (All levels)
  • Moderators: Khashayar Farsad, MD, PhD, Memorial Sloan Kettering Cancer Center; Clifford R. Weiss, MD, FSIR, FCIRSE, Johns Hopkins University School of Medicine; Florian J. Fintelmann, MD, Massachusetts General Hospital
• 3:15 - 3:30 p.m. - Product Theatre presented by RenovoRx

Must-Know Papers (100)

Moderators: Rony Avritshcer, MD, MD Anderson Cancer Center; Terence P. Gade, MD, PhD, University of Pennsylvania

• IMbrave/150/Himalaya Trilas, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
• Intraprocedural versus initial follow-up ablative marigin assessment after mCRC Liver Ablation, Ethan Lin, MD, MD Anderso Cancer Center
• MRI-guided stereotactic ablative body radiotherapy versus CT-guided pancreatic IRE, Florentine Timmer, MD, Amsterdam UMC
• Sublobar resection, Stereotactic Body Radiation Therapy and Percutaneous ablation for lung cancer, Matthew Callstrom, MD, PhD, Mayo Clinic
• Percutaneous MWA versus robot-assisted partial nephrectomy for stage I RCC, Dimitrios Filippiaidis, MD, PhD, MSc, EBIR, National and Kapodistrian University of Athens

Hands-on Y90 Dosimetry Block 1* (200)

*Pre-registration is required to secure a workstation, at no additional fee. Participants will work in pairs to apply contouring principles for practical application. This session will use the MIM software as a primary example. Registrants are strongly encouraged to attend both blocks for a well-rounded educational experience. Additional space will be available for observers based on room capacity.

Moderator: Nima Kokabi, MD, University of North Carolina Chapel Hill

Faculty: Juan Martin Gimenez, MD, Ocshner Health; Tyler Sandow, MD, Ocshner Health; David S. Wang, MD, FSIR, Stanford Medicine; Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Osman Ahmed, MD, University of Chicago; Beau Toskich, MD, Mayo Clinic

Ablation vs. Radiation Debate: SIO Meets ASTRO (200)

Moderators: Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; David Breen, MD, FRCR, University Hospitals Southampton; Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University

• Liver, Riad Salem, MD, MBA, Northwestern and Mekhail Anwar, MD, PhD, UC San Francisco and UC Berkeley
• Renal Cancer, Thomas Atwell, MD, FSIR, Mayo Clinic and Chad Tang, MD, MD Anderson Cancer Center
• Spinal Curative, Jason R. Levy, MD, FSIR, Northside Hospital and James Urbanic, MD, University of California San Diego

Breakfast and CME Session: Optimal Preparation and Treatment Endpoints in cTACE (200)

Breakfast will be provided. Following the overview, participants will engage in hands-on learning at workstations supervised by expert faculty

• Overview, Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

Faculty: Nicholas Fidelman, MD, University of California San Francisco; Irene Bargellini, MD, Candiolo Cancer Institute and University of Turin; Nishita Kothary, MD, Stanford School of Medicine; Juan Martin Gimenez, MD, Ocshner Health; William Rilling, MD, FSIR, Medical College of Wisconsin; Tyler Sandow, MD, Ocshner Health; Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Nadine Abi-Jaoudeh, MD, University of California Irvine

IO Essentials: Sponsored Content 5 (100)

BCLC C HCC Debate "Who's on First?" (200)

Moderators: Riad Salem, MD, MBA, Northwestern; Roberto Iezzi, MD, FCIRSE, Policlinico A Gemelli - IRCCS - Università Cattolica

• Lobar or Sublobar Portal Vein Invasion, Gregory Nadolksi, MD, University of Pennsylvania and Amit Singal, MD, UT Southwestern Medical Center
• Bilobar or Main Portal Vein Invasion, Daniel Sze, MD, PhD, Stanford University and Marina Baretti, MD, Johns Hopkins School of Medicine
• Patients with Vascular Invasion and Regional Metastases, Guy Johnson, MD, PharmD, University of Washington and Richard S. Finn, MD, Geffen School of Medicine at UCLA

Robotics/Navigation/Guidance/Confirmation (200)

Moderators: Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center; Nadine Abi-Jaoudeh, MD, University of California Irvine

• Augmented Reality, Terence P. Gade, MD, PhD, University of Pennsylvania
• Technical Principles of Navigation, Iwan Paolucci, PhD, D Anderson Cancer Center
• Procedure Planning and Guidance, Nadine Abi-Jaoudeh, MD, University of California Irvine
• Robotics, Luigi A.Solbiati, MD, Humanitas University and Research Hospital
• Confirmation, Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center

Discovery Theatre Programming

• Internet: Friend or Foe? (All levels)
  • Julius Chapiro, MD, PhD, Yale University School of Medicine; Dianne Keen, FRMBA, AbbaDox; Nadine Abi-Jaoudeh, MD, University of California Irvine

Scientific Oral Abstracts (200)

Moderators: Isabel Gala Newton, MD, PhD, VASDMC and UCSD;  Brad J. Wood, MD, NIH NCI NIBIB

Y90 Clinical Applications (200)

Moderators: Charles Y. Kim, MD, Duke University; Robert Lewandowski, MD, FSIR; Northwestern Medicine

• Strategies for Diffuse Bilobar Disease, Charles Y. Kim, MD, Duke University
• Approach to Challenging Patients, Thomas Helmberger, MD, PhD, Munich Klinik Bogenhausen
• Extra-hepatic Applications, Robert Lewandowski, MD, FSIR; Northwestern Medicine
• Holmium-166 and the RALLY Study, Marnix Lam, MD, PhD, University Medical Center Utrecht

Exhibit Hall Open

Lunch and Industry Symposium

Discovery Theatre Programming

• 12:15 - 12:45 p.m. - Industry Abstract Presentations (All levels)
  • Moderator: Isabel Gala Newton, MD, PhD, VASDMC and UCSD
• 12:45 - 1:00 p.m. - Product Theatre

Future Liver Remnant (200)

Moderator: Peiman Habibollahi, MD, MD Anderson Cancer Center; Nishita Kothary, MD, Stanford School of Medicine

• Surgical Techniques and Estimation of Functional Liver Reserve, Eric Nakakura, MD, PHD, University of California San Francisco
• PVE: Which Embolic to Choose? Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE, INCA Brazilian National Cancer Institute
• Total Venous Deprivation, Francesco de Cobelli, MD, San Raffaele Hospital and Salute University
• Radiation Lobectomy: Updates and Trials in Progress, Resmi Charalel, MD, MPH, Weill Cornell Medicine

MSK Tumor Board (200)

Moderators: Afshin Gangi, MD, PhD, University Hospital Strasbourg, King’s College London; Brandon M. Key, MD, Medical College of Wisconsin

• Pathalogic Fractures: IR Approach, Steven Yevich, MD, MPH, MD Anderson Cancer Center
• Pathalogic Fractures: Orthopedic Approach, Melissa Zimel, MD, University of California San Francisco
• Ablation and Vertebral Augmentation: Neuroprotective Techniques, Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University
• Electrochemotherapy, Frederic Deschampes, MD, PhD, Gustave Roussy
• Tumor Board, All session faculty listed above, Christian Meyer, MD, PhD, Johns Hopkins Hospital

Robotics/Navigation/Guidance/Confirmation Hands-on (All levels)

Moderator: Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center

Faculty: Iwan Paolucci, PhD, D Anderson Cancer Center; Francois H. Cornelis, MD, PhD, Memorial Sloan Kettering Cancer Center; Keith M. Horton, MD, FSIR, MedStar Health/Georgetown University School of Medicine; Luigi A.Solbiati, MD, Humanitas University and Research Hospital; Stephen J. Hunt, MD, PhD, FSIR, University of Pennsylvania; Brian Park, MD, OHSU; Alex King, MBBS, MRCS, FRCR, University Hospitals Southampton; Sean Merrill Tutton, MD, UCSD Health

Discovery Theatre Programming

• 2:45 - 3:15 p.m. - IO in OBL (All levels)
  • David Sperling, MD, FSIR, Columbia University Irving Medical Center; Scott Genshaft, MD, UCLA; Jayson S. Brower, MD, Inland Imaging
• 3:15 - 3:30 p.m. - Product Theatre

SIO Grants (200)

Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Christopher D. Malone, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine

• 2023 Grant Update: Spatial proteogenomics for prediction of response in combined radioembolization and immunotherapy of HCC, Elif Öcal, MD, LMU
• 2022 Grant Update: Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant, Isabel Gala Newton, MD, PhD, VASDMC and UCSD
• 2022 Grant Update: Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer, Kiyoyuki Minamiguchi, MD, PhD, Nara Medical University
• 2022 Grant Update: Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC, S. Nahum Goldberg, MD, Beth Israel Deaconess Medical Center/Harvard Medical School
• 2022 Grant Update: Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC, David Tischfield, MD, PhD, University of Pennsylvania
• Interactive Debate, All

Melanoma (200)

Moderators: David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital; Gloria Hwang, MD, FSIR, Stanford University

• Building a Multidisciplinary Melanoma Program, Robert Adamo, MD, Thomas Jefferson University Hospital
• Relative advantages of chemoembolization and immunoembolization, David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital
• Y90 with or without Immunotherapy, Gloria Hwang, MD, FSIR, Stanford University
• Ablative Techniques with or without Immunotherapy, Chenyang Zhan, MD, PhD, Memorial Sloan Kettering Cancer Center
• Delcath, Alexander Villalobos, MD, University of North Carolina Chapel Hill

Hands-on Y90 Dosimetry Block 2* (200)

*Pre-registration is required to secure a workstation, at no additional fee. Participants will work in pairs to apply contouring principles for practical application. This session will use the Simplicit90Y software as a primary example. Registrants are strongly encouraged to attend both blocks for a well-rounded educational experience. Additional space will be available for observers based on room capacity.

Moderator: Juan Martin Gimenez, MD, Ocshner Health;

Faculty: Tyler Sandow, MD, Ocshner Health; David S. Wang, MD, FSIR, Stanford Medicine; Osman Ahmed, MD, University of Chicago; Beau Toskich, MD, Mayo Clinic; others TBD

Oligometastatic Disease Tumor Board (200)

Moderators: Martijn R. Meijerink, MD, PhD, FCIRSE, Amsterdam UMC; Alexios Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens; A. Nick Kurup, MD, Mayo Clinic

Panelists: Afshin Gangi, MD, PhD, University Hospital Strasbourg, King’s College London; Terence Friedlander, MD, University of California San Francisco; Mekhail Anwar, MD, PhD, UC San Franscico and UC Berkeley

Sunday Soiree* at Alexxa's Las Vegas
*Attendance requires an additional fee.

Breakfast

Practical IO (All levels)

Moderators: Nicholas Fidelman, MD, University of California San Francisco; Aneesa Majid, MD, MBA, Independent

Case presentations by:

• Vladimir Sheynzon, MD, MBA, Columbia University Irving Medical Center
• Gaby E. Gabriel, MD, FSIR, University of Kentucky
• Gina Landinez, MD, MCVI MCI
• David S. Wang, MD, FSIR, Stanford Medicine
• Scott Genshaft, MD, UCLA
• Rajesh Shah, MD, UCSF
• Eric Wehrenberg-Klee, MD, Massachusetts General Hospital
• Ahmad Parvinian, MD, Mayo Clinic
• James Ronald, MD, PhD, Duke University
• Tony Brown, MD, RIA Endovascular
• Todd Schlachter, MD, Yale School of Medicine
• Jin Woo Choi, MD, PhD, Seoul National University Hospital

Case-based Review: M&M (All levels)

Moderators: Daniel Sze, MD, PhD, Stanford University; Charles Nutting, DO, FSIR, Image Guided Therapy

Case presentations by:

• Jeffrey Weinstein, MD, FSIR, Beth Isreal Deaconess Medical Center/Harvard Medical School
• Matthew J. Scheidt, MD, FSIR, Froedtert and the Medical College of Wisconsin
• Jonathan Kessler, MD, City of Hope
• Ken Zhao, MD, Memorial Sloan Kettering Cancer Center
• Igor Latich, MD, Yale University
• Kirema Garcia-Reyes, MD, Icahn School of Medicine at Mount Sinai
• Alex King, MBBS, MRCS, FRCR, University Hospitals Southampton
• Lambros Tselikas, MD, PhD, Gustave Roussy
• Jonathan Morris, MD, Mayo Clinic
• Juan Carlos Perez Lozada, MD, Yale School of Medicine
• Donna D'Souza, MD, FSIR, University of Minnesota
• Elena Violari, MD, Radiology Partners, Franciscan Alliance Hospitals